Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-023335
Filing Date
2024-09-12
Accepted
2024-09-12 20:40:50
Documents
1
Period of Report
2024-09-11

Document Format Files

Seq Description Document Type Size
1 form4-09132024_120946.html 4  
1 form4-09132024_120946.xml 4 3732
  Complete submission text file 0001415889-24-023335.txt   5224
Mailing Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361
Business Address 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 805-267-9889
GENELUX Corp (Issuer) CIK: 0001231457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6400
Business Address
Tyree James L (Reporting) CIK: 0001324991 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41599 | Film No.: 241296216